FMS - Fresenius Medical Care Non-GAAP EPS of Euro0.90 revenue of Euro4.64B
Fresenius Medical Care press release (NYSE:FMS): Q4 Non-GAAP EPS of €0.90. Revenue of €4.64B (+5.5% Y/Y). Company expects revenue and net income to grow at low to mid-single digit percentage rates in FY 2022
For further details see:
Fresenius Medical Care Non-GAAP EPS of €0.90, revenue of €4.64B